Edgewise Therapeutics
Corporate brand
UnclaimedEdgewise Therapeutics is a Boulder, Colorado-based company developing novel therapeutics for serious cardiovascular diseases.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Edgewise Therapeutics is a company headquartered in Boulder, Colorado, dedicated to transforming cardiovascular disease. It focuses on serious cardiovascular diseases with life-limiting impact, including hypertrophic cardiomyopathy (HCM) and heart failure (HF), including heart failure with preserved ejection fraction (HFpEF). The company describes a science-driven, patient-centered culture and pursues novel therapeutics for these conditions.
History
Edgewise Therapeutics is a company headquartered in Boulder, Colorado. It chose Boulder, Colorado, for its headquarters, establishing a life science nexus. The company is dedicated to transforming cardiovascular disease and focuses on serious cardiovascular diseases with life-limiting impact, including hypertrophic cardiomyopathy (HCM) and heart failure (HF), including heart failure with preserved ejection fraction (HFpEF). It describes a science-driven culture that places patients first and pursues novel therapeutics for these conditions.
Products and positioning
Dedicated to transforming cardiovascular disease through novel therapeutics, with a science-driven and patient-centered approach.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/edgewise-therapeutics-united-states · Editorial policy · How profiles are compiled